APO RESEARCH · REPORT
Tuberculosis (TB) Diagnostics
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Product & engineering
Understand the product.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Selected research
Industry Research
Tuberculosis (TB) Diagnostics Industry Research Report 2026
Market perspective
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
Read the full market overview
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report quantifies the global Tuberculosis (TB) Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Tuberculosis (TB) Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tuberculosis (TB) Diagnostics Market by Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Segment by Application
Diagnostic Laboratories
Hospitals
Tuberculosis (TB) Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
Applications
- Diagnostic Laboratories
- Hospitals
Companies covered
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tuberculosis (TB) Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Culture-Based Diagnostics
- 2.2.3 Sputum Smear Microscopy
- 2.2.4 Rapid Molecular Diagnostics
- 2.2.5 Others
- 2.3 Tuberculosis (TB) Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostic Laboratories
- 2.3.3 Hospitals
- 2.4 Assumptions and Limitations
3 Tuberculosis (TB) Diagnostics Breakdown Data by Type
- 3.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2027-2032)
4 Tuberculosis (TB) Diagnostics Breakdown Data by Application
- 4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2021-2032)
- 5.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
- 5.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 Tuberculosis (TB) Diagnostics Market Dynamics
- 5.3.1 Tuberculosis (TB) Diagnostics Industry Trends
- 5.3.2 Tuberculosis (TB) Diagnostics Market Drivers
- 5.3.3 Tuberculosis (TB) Diagnostics Market Challenges
- 5.3.4 Tuberculosis (TB) Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
- 6.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global Tuberculosis (TB) Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Tuberculosis (TB) Diagnostics Head Office and Area Served
- 6.4 Global Tuberculosis (TB) Diagnostics Players, Product Type & Application
- 6.5 Global Tuberculosis (TB) Diagnostics Manufacturers Established Date
- 6.6 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Tuberculosis (TB) Diagnostics Market Size (2021-2032)
- 7.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 7.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Tuberculosis (TB) Diagnostics Market Size (2021-2032)
- 8.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Tuberculosis (TB) Diagnostics Market Size (2021-2032)
- 10.2 South America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 10.4 South America Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Danaher
- 12.1.1 Danaher Company Information
- 12.1.2 Danaher Business Overview
- 12.1.3 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
- 12.1.5 Danaher Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 Thermo Fisher Scientific
- 12.3.1 Thermo Fisher Scientific Company Information
- 12.3.2 Thermo Fisher Scientific Business Overview
- 12.3.3 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
- 12.3.5 Thermo Fisher Scientific Recent Developments
- 12.4 BD
- 12.4.1 BD Company Information
- 12.4.2 BD Business Overview
- 12.4.3 BD Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
- 12.4.5 BD Recent Developments
- 12.5 Abbott
- 12.5.1 Abbott Company Information
- 12.5.2 Abbott Business Overview
- 12.5.3 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
- 12.5.5 Abbott Recent Developments
- 12.6 Hologic
- 12.6.1 Hologic Company Information
- 12.6.2 Hologic Business Overview
- 12.6.3 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
- 12.6.5 Hologic Recent Developments
- 12.7 Qiagen
- 12.7.1 Qiagen Company Information
- 12.7.2 Qiagen Business Overview
- 12.7.3 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
- 12.7.5 Qiagen Recent Developments
- 12.8 BioMerieux
- 12.8.1 BioMerieux Company Information
- 12.8.2 BioMerieux Business Overview
- 12.8.3 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
- 12.8.5 BioMerieux Recent Developments
- 12.9 Hain Lifescience
- 12.9.1 Hain Lifescience Company Information
- 12.9.2 Hain Lifescience Business Overview
- 12.9.3 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
- 12.9.5 Hain Lifescience Recent Developments
- 12.10 Oxford Immunotec
- 12.10.1 Oxford Immunotec Company Information
- 12.10.2 Oxford Immunotec Business Overview
- 12.10.3 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2021-2026)
- 12.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
- 12.10.5 Oxford Immunotec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst